Publications by authors named "Talia Golan"

63Publications

Effect of the botanical compound LCS102 on innate immunity.

Biomed Rep 2020 Sep 2;13(3):17. Epub 2020 Jul 2.

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/br.2020.1323DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391288PMC
September 2020

ASO Author Reflections: Pancreatic Cancer Patients with Germline BRCA Mutations Benefit from Early Introduction of Platinum-Based Chemotherapy.

Ann Surg Oncol 2020 Oct 27;27(10):3971-3972. Epub 2020 Apr 27.

Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-020-08495-6DOI Listing
October 2020

Correction: Exclusive destruction of mitotic spindles in human cancer cells.

Oncotarget 2020 Apr 7;11(14):1290-1291. Epub 2020 Apr 7.

The Neufeld Cardiac Research Institute, Department of Physiology and Pharmacology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.27499DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147084PMC
April 2020

Correction: The phenanthrene derivative PJ34 exclusively eradicates human pancreatic cancer cells in xenografts.

Oncotarget 2020 Feb 4;11(5):571-572. Epub 2020 Feb 4.

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.27440DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007295PMC
February 2020

The phenanthrene derivative PJ34 exclusively eradicates human pancreatic cancer cells in xenografts.

Oncotarget 2019 Oct 22;10(58):6269-6282. Epub 2019 Oct 22.

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.27268DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817443PMC
October 2019

Maintenance Olaparib for Metastatic Pancreatic Cancer. Reply.

N Engl J Med 2019 10;381(15):1492-1493

University of Chicago, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1911185DOI Listing
October 2019

Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition.

Mol Cancer Res 2019 10 5;17(10):2029-2041. Epub 2019 Aug 5.

Department of Surgery, Jefferson Pancreas, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-19-0589DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794000PMC
October 2019

Lung Metastasis Predicts Better Prognosis in Metastatic Colorectal Cancer With Mutated KRAS.

Clin Colorectal Cancer 2019 09 26;18(3):e300-e307. Epub 2019 Jun 26.

Department of Oncology, Sheba Medical Center, Tel-Hashomer, Israel; Tel-Aviv University, Tel-Aviv, Israel; Division of Gastroenterology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2019.06.001DOI Listing
September 2019

Maintenance Olaparib for Germline -Mutated Metastatic Pancreatic Cancer.

N Engl J Med 2019 07 2;381(4):317-327. Epub 2019 Jun 2.

From the Oncology Institute, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel (T.G.); Hôpital Beaujon (Assistance Publique-Hôpitaux de Paris), Clichy, and University Paris VII, Paris (P.H.); IRCCS Ospedale San Raffaele Scientific Institute, Milan (M.R.), Azienda Ospedaliera Universitaria Integrata Verona, Verona (G.T.), and Fondazione Policlinico Universitario Gemelli IRCCS, Rome (G.T.) - all in Italy; University Hospitals Gasthuisberg and KU Leuven, Leuven, Belgium (E.V.C.); Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona (T.M.); Fox Chase Cancer Center, Philadelphia (M.J.H.); Samsung Medical Center, Sungkyunkwan University School of Medicine (J.-O.P.), and Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine (D.-Y.O.) - both in Seoul, South Korea; University College London Cancer Institute, London (D.H.), and AstraZeneca, Cambridge (D.M.) - both in the United Kingdom; Asklepios Tumorzentrum Hamburg Asklepios Klinik Altona, Hamburg (D.A.), St. Josef-Hospital, Ruhr University Bochum, Bochum (A.R.-S.), and Klinikum rechts der Isar, Department of Internal Medicine II, Technische Universität München, Munich (H.A.) - all in Germany; Memorial Sloan Kettering Cancer Center, New York (E.M.O.); AstraZeneca, Gaithersburg, MD (K.Y.C., G.Y.L.); Merck, Kenilworth, NJ (K.S.); and the University of Chicago, Chicago (H.L.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1903387DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810605PMC
July 2019

Postoperative Radiation for Pathologic Stage T4 Colon Cancers Receiving Adjuvant Chemotherapy.

Clin Colorectal Cancer 2019 09 13;18(3):226-230.e2. Epub 2019 Apr 13.

Department of Oncology, Sheba Medical Center, Tel-Hashomer, Israel; Tel-Aviv University, Tel-Aviv, Israel; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15330028183052
Publisher Site
http://dx.doi.org/10.1016/j.clcc.2019.04.004DOI Listing
September 2019

Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases.

Cancer Cell 2019 02 24;35(2):267-282.e7. Epub 2019 Jan 24.

PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada; Department of Surgery, University of Toronto, Toronto, ON M5T 1P5, Canada; Hepatobiliary/Pancreatic Surgical Oncology Program, University Health Network, Toronto, ON M5G 2M9, Canada; Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15356108183058
Publisher Site
http://dx.doi.org/10.1016/j.ccell.2018.12.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398439PMC
February 2019

LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial.

J Cachexia Sarcopenia Muscle 2018 10 27;9(5):871-879. Epub 2018 Jul 27.

Rabin Medical Center, Petach Tikva, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcsm.12331DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204586PMC
October 2018

Harnessing the Perioperative Period to Improve Long-term Cancer Outcomes.

J Natl Cancer Inst 2018 10;110(10):1137-1138

Oncology Institute, Sheba Medical Center at Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/advance-article/doi/10.1093/jn
Publisher Site
http://dx.doi.org/10.1093/jnci/djy055DOI Listing
October 2018

A new look at the International Duration Evaluation of Adjuvant therapy (IDEA) classification-Defining novel predictive and prognostic markers in stage III colon cancer.

Eur J Cancer 2018 06 24;96:105-110. Epub 2018 Apr 24.

Department of Oncology, Sheba Medical Center, Tel-Hashomer, Israel; Tel-Aviv University, Tel-Aviv, Israel; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2018.03.022DOI Listing
June 2018

Assessing the prognostic value of carcinoembryonic antigen levels in stage I and II colon cancer.

Eur J Cancer 2018 05 20;94:1-5. Epub 2018 Mar 20.

Department of Oncology, Sheba Medical Center, Tel-Hashomer, Israel; Tel-Aviv University, Tel-Aviv, Israel; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2018.01.112DOI Listing
May 2018

DNA Repair Dysfunction in Pancreatic Cancer: A Clinically Relevant Subtype for Drug Development.

J Natl Compr Canc Netw 2017 08;15(8):1063-1069

The University of Texas MD Anderson Cancer Center, Houston, Texas

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2017.0133DOI Listing
August 2017

Exclusive destruction of mitotic spindles in human cancer cells.

Oncotarget 2017 Mar;8(13):20813-20824

The Neufeld Cardiac Research Institute, Department of Physiology and Pharmacology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.15343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400547PMC
March 2017

Changing the course of pancreatic cancer--Focus on recent translational advances.

Cancer Treat Rev 2016 Mar 25;44:17-25. Epub 2016 Jan 25.

MD Anderson Cancer Center, 1515, Holcombe Blvd, Unit 426, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2016.01.004DOI Listing
March 2016

Changing prognosis of metastatic colorectal adenocarcinoma: Differential improvement by age and tumor location.

Cancer 2013 Aug 29;119(16):3084-91. Epub 2013 May 29.

Oncology Institute at the Chaim Sheba Medical Center, Tel-Hashomer, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28143DOI Listing
August 2013

Parametric diffusion tensor imaging of the breast.

Invest Radiol 2012 May;47(5):284-91

Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLI.0b013e3182438e5dDOI Listing
May 2012

The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancer.

Fam Cancer 2012 Jun;11(2):243-7

The Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, The Chaim Sheba Medical Center, 52621, Tel HaShomer, Israel.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10689-011-9507-1
Publisher Site
http://dx.doi.org/10.1007/s10689-011-9507-1DOI Listing
June 2012

Targeting the insulin growth factor pathway in gastrointestinal cancers.

Oncology (Williston Park) 2011 May;25(6):518-26, 529

Sheba Medical Center, Tel Hashomer, Israel.

View Article

Download full-text PDF

Source
May 2011

Cetuximab in metastatic colorectal cancer.

Lancet Oncol 2010 Apr;11(4):313-4; author reply 314

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(10)70019-XDOI Listing
April 2010

Chimeric molecule IL-6/soluble IL-6 receptor is a potent mitogen for fetal hepatocytes.

J Cell Physiol 2004 Aug;200(2):245-52

Liver Unit, Gastroenterology Institute, Tel Aviv Sourasky Medical Center, Weizman 6, Tel Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.20019DOI Listing
August 2004